Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Neuroendocrine Tumors and TSC2[original query] |
---|
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors. International journal of biological sciences 2016 12 (12): 1523-1532. Chou Wen-Chi, Lin Po-Han, Yeh Yi-Chen, Shyr Yi-Ming, Fang Wen-Liang, Wang Shin-E, Liu Chun-Yu, Chang Peter Mu-Hsin, Chen Ming-Han, Hung Yi-Ping, Li Chung-Pin, Chao Yee, Chen Ming-Hua |
Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel. Oncotarget 2017 Nov 8 (55): 93464-93475. Gleeson Ferga C, Voss Jesse S, Kipp Benjamin R, Kerr Sarah E, Van Arnam John S, Mills John R, Marcou Cherisse A, Schneider Amber R, Tu Zheng Jin, Henry Michael R, Levy Michael |
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times. Gastroenterology 2018 2 154 (8): 2060-2063.e8. Roy Somak, LaFramboise William A, Liu Ta-Chiang, Cao Dengfeng, Luvison Alyssa, Miller Caitlyn, Lyons Maureen A, O'Sullivan Roderick J, Zureikat Amer H, Hogg Melissa E, Tsung Allan, Lee Kenneth K, Bahary Nathan, Brand Randall E, Chennat Jennifer S, Fasanella Kenneth E, McGrath Kevin, Nikiforova Marina N, Papachristou Georgios I, Slivka Adam, Zeh Herbert J, Singhi Aatur |
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors. Annals of surgery 2019 10 274 (6): e949-e956. Uemura Jun, Okano Keiichi, Oshima Minoru, Suto Hironobu, Ando Yasuhisa, Kumamoto Kensuke, Kadota Kyuichi, Ichihara Shuji, Kokudo Yasutaka, Maeba Takashi, Nanno Yoshihide, Toyama Hirochika, Takada Yasutsugu, Shimada Mitsuo, Hanazaki Kazuhiro, Masaki Tsutomu, Suzuki Yasuyu |
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability. JCO precision oncology 2019 1 2018 . Raj Nitya, Shah Ronak, Stadler Zsofia, Mukherjee Semanti, Chou Joanne, Untch Brian, Li Janet, Kelly Virginia, Saltz Leonard B, Mandelker Diana, Ladanyi Marc, Berger Michael F, Klimstra David S, Reidy-Lagunes Diane, Osoba Muyin |
Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA). Orphanet journal of rare diseases 2021 Jul 16 (1): 301. Sauter Matthias, Belousova Elena, Benedik Mirjana P, Carter Tom, Cottin Vincent, Curatolo Paolo, Dahlin Maria, D'Amato Lisa, d'Augères Guillaume B, de Vries Petrus J, Ferreira José C, Feucht Martha, Fladrowski Carla, Hertzberg Christoph, Jozwiak Sergiusz, Lawson John A, Macaya Alfons, Marques Ruben, Nabbout Rima, O'Callaghan Finbar, Qin Jiong, Sander Valentin, Shah Seema, Takahashi Yukitoshi, Touraine Renaud, Youroukos Sotiris, Zonnenberg Bernard, Jansen Anna, Kingswood J Chris, |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: